Phase 2 Open-Label Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe SLE With Lupus Nephritis Post author: Post published:November 5, 2026 Post category: Continue ReadingPhase 2 Open-Label Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe SLE With Lupus Nephritis
Phase 2 Open-Label Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe SLE With Lupus Nephritis Post author: Post published:November 5, 2026 Post category: Continue ReadingPhase 2 Open-Label Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe SLE With Lupus Nephritis
